| | ||||||
| Financial Markets | ||||||
| NEWS | ||||||
| China targets $3 billion of US goods in tariff spat BEIJING — China announced a $3 billion list of U.S. goods for possible retaliation in a tariff dispute with President Donald Trump and girded Friday for a bigger battle over technology policy as financial markets sank on fears of global disruption. Trump said Friday that he was not concerned that the tariffs ...
| ||||||
| China targets $3 billion of US goods BEIJING — China announced a $3 billion list of U.S. goods for possible retaliation in a tariff dispute with President Donald Trump and girded Friday for a bigger battle over technology policy as financial markets sank on fears of global disruption. The Commerce Ministry said higher duties on pork, apples, ...
| ||||||
| How Does Dow Jones Drop Effect Cryptocurrency? However, this has brought boundless fear that China may strike back and financial market over the world will be diving into further chaos. Analysts anticipate that there will be a further decline, with some even suggesting this could be the start of a setback for the multi-year bull trend responsible for the ...
| ||||||
| Stocks tumble on trade fears; S&P has worst week in 2 years The market's two biggest sectors slumped the most. Technology stocks have made enormous gains over the past year, but since they do so much business outside the U.S., investors see them as particularly vulnerable in a trade dispute. The sector dropped 7.9 percent this week. Banks also fell sharply.
| ||||||
| Ladenburg Thalmann Financial Services Inc. Has $2.09 Million Stake in WisdomTree Emerging ... WisdomTree Emerging Markets Eqty Incm Fd logo Ladenburg Thalmann Financial Services Inc. raised its holdings in shares of WisdomTree Emerging Markets Eqty Incm Fd (NYSEARCA:DEM) by 10.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC.
| ||||||
| AbbVie (ABBV) PT Set at $95.00 by BMO Capital Markets AbbVie logo AbbVie (NYSE:ABBV) has been assigned a $95.00 price objective by research analysts at BMO Capital Markets in a note issued to investors on Thursday. The firm presently has a "sell" rating on the stock. BMO Capital Markets' price objective would suggest a potential downside of 2.52% ...
| ||||||
| See more results | Edit this alert | ||||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
No comments:
Post a Comment